Ligand to Present at Acumen BioFin Rodman & Renshaw Health Conference on November 5
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that John L. Higgins, President and Chief Executive Officer and Martin Meglasson, Vice President of Discovery Research, will both present at the Acumen BioFin Rodman & Renshaw Healthcare Conference on Monday, November 5, 2007, at 3:45 p.m. Eastern time (12:45 p.m. Pacific). The conference takes place at The New York Palace Hotel in New York City.
A live webcast of the presentation will be available on the Company's website www.ligand.com. A replay of the presentation will be archived on the site for 30 days.
About Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of thrombocytopenia, hepatitis C, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Source: Ligand Pharmaceuticals Incorporated
Released November 1, 2007